Aro Biotherapeutics
Melissa Brookes is currently serving as the Vice President Clinical Operations at Aro Biotherapeutics since February 2022. Prior to this role, Melissa held the position of Senior Director Clinical Operations at Caribou Biosciences from 2021 to 2022. With a background in clinical development, Melissa has worked at various companies such as Galera Therapeutics, Inc., Merck, and Genentech in senior roles. Melissa's career trajectory showcases their expertise and experience in the pharmaceutical industry, making their a valuable asset to any organization Melissa is a part of. Melissa holds a degree from Mansfield University of Pennsylvania, where Melissa completed their education in 1997.
This person is not in any teams
Aro Biotherapeutics
Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.